Browsing by Author Zhu, Andrew X.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 5 of 5
TitleAuthor(s)Issue Date
 
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
Journal:Journal of Experimental & Clinical Cancer Research
Chan, Stephen L.Schuler, MartinKang, Yoon KooYen, Chia JuiEdeline, JulienChoo, Su PinLin, Chia ChiOkusaka, TakujiWeiss, Karl HeinzMacarulla, TeresaCattan, StéphaneBlanc, Jean FredericLee, Kyung HunMaur, MichelaPant, ShubhamKudo, MasatoshiAssenat, EricZhu, Andrew X.Yau, ThomasLim, Ho YeongBruix, JordiGeier, AndreasGuillén-Ponce, CarmenFasolo, AngelicaFinn, Richard S.Fan, JiaVogel, ArndtQin, ShukuiRiester, MarkusKatsanou, VasilikiChaudhari, MonicaKakizume, TomoyukiGu, YiPorta, Diana GrausMyers, AndreaDelord, Jean Pierre
2-Jun-2022
 
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
Journal:The Lancet Oncology
Kelley, Robin KateRimassa, LorenzaCheng, Ann LiiKaseb, AhmedQin, ShukuiZhu, Andrew X.Chan, Stephen L.Melkadze, TamarSukeepaisarnjaroen, WattanaBreder, ValeryVerset, GontranGane, EdwardBorbath, IvanRangel, Jose David GomezRyoo, Baek YeolMakharadze, TamtaMerle, PhilippeBenzaghou, FawziBanerjee, KamalikaHazra, SaswatiFawcett, JonathanYau, Thomas
1-Aug-2022
 
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Journal:Nature Medicine
Zhu, Andrew X.Abbas, Alexander R.de Galarreta, Marina RuizGuan, YinghuiLu, ShanKoeppen, HartmutZhang, WenjunHsu, Chih HungHe, Aiwu RuthRyoo, Baek YeolYau, ThomasKaseb, Ahmed O.Burgoyne, Adam M.Dayyani, FarshidSpahn, JessicaVerret, WendyFinn, Richard S.Toh, Han ChongLujambio, AmaiaWang, Yulei
23-Jun-2022
 
Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non–Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2
Journal:The Oncologist
Finn, Richard S.Yau, ThomasHsu, Chih HungDe Toni, Enrico N.Goyal, LipikaGalle, Peter R.Qin, Shu KuiRao, SujataSun, FangfangWang, ChunxiaoWidau, Ryan C.Zhu, Andrew X.
9-Dec-2022
 
Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib
Journal:European Journal of Cancer
Kudo, MasatoshiFinn, Richard S.Edeline, JulienCattan, StéphaneOgasawara, SadahisaPalmer, Daniel H.Verslype, ChrisZagonel, VittorinaFartoux, LaetitiaVogel, ArndtSarker, DebashisVerset, GontranChan, Stephen L.Knox, JenniferDaniele, BrunoYau, Chung Cheung ThomasGurary, Ellen B.Siegel, Abby B.Wang, AnranCheng, Ann LiiZhu, Andrew X.
19-Mar-2022
Showing results 1 to 5 of 5